TTUHSC researcher receives patent for schistosomiasis vaccine - Lubbock AJ

Lubbock AJ - Dr. Afzal Siddiqui received patent for a vaccine he created through TTUHSC research to treat schistosomiasis.

The disease is more prevalent in countries outside the continental United States, potentially putting 800 million people at risk.

“This vaccine is a chance to improve the lives of 200 million people,” said Dr. Michael Conn, vice president of research for TTUHSC, in reference to the number of people affected by the disease. “This kind of opportunity doesn’t come along often.”

Read the full story

Related Stories

Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership

From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.

Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas

The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.

TTUHSC Names New Regional Dean for the School of Nursing

Louise Rice, DNP, RN, has been named regional dean of the TTUHSC School of Nursing on the Amarillo campus.

Recent Stories

Research

TTUHSC’s Hudson Set to Serve as President for Society of Clinical Research Associates

The Society of Clinical Research Associates (SOCRA) has elected Texas Tech University Health Sciences Center’s (TTUHSC) Catherine Hudson, Dr.P.H., as its president for 2025-2026.

Research

Clinical Research Institute a Source of Pride for Retiring Griswold

Upon his retirement, John Griswold, M.D., reflects on the Clinical Research Institute and what it has achieved.

Research

Abid Brings Hematology Expertise to TTUHSC Oncology Team

Muhammad Bilal Abid, M.D., has joined the TTUHSC School of Medicine oncology team as an associate professor of internal medicine and medical director of TTUHSC’s Blood and Marrow Transplantation & Cellular Therapy Program.